期刊文献+

腹膜后淋巴清扫术对原发性输卵管癌生存预后的影响 被引量:1

The survival effect of systematic lymphadenectomy in primary fallopian tube cancer:an analysis of 67 cases
原文传递
导出
摘要 目的探讨腹膜后淋巴清扫术在原发性输卵管癌(PFTC)治疗中的作用。方法回顾性分析天津医科大学总医院与天津市中心妇产科医院1995年1月至2008年6月收治的临床资料完整PFTC病例67例,分析腹膜后淋巴清扫术对生存预后的影响并探讨影响PFTC预后的相关因素。结果早期(Ⅰ期和Ⅱ期)患者行腹膜后淋巴清扫者的总生存期(OS)和无进展生存期(PFS)均好于未行腹膜后淋巴清扫者(P=0.020,P=0.025),而晚期患者无论是否行腹膜后淋巴清扫术其OS与PFS差异无统计学意义(P=0.574,P=0.810)。淋巴结阳性患者的OS与PFS均短于阴性者(P<0.001,P<0.001)。临床分期、腹膜后淋巴结转移、术后残余病灶是PFTC生存预后的独立因素(P=0.021,P=0.038,P=0.031)。结论早期PFTC应行包括腹膜后淋巴清扫术在内的全面分期手术,使患者获得准确的手术分期及恰当的术后辅助治疗;晚期病例采取肿瘤细胞减灭术,尽量缩小残余病灶,以延长患者生存期。 Objective To evaluate the value of systematic lymphadeneetomy (SL) in the treatment of primary fallopian tube cancer (PFFC). Method Retrospectively analyze 67 cases of PFTC who were treated in Tianjin Medical University General Hospital and Tianjin Central Hospital of O&G between Jan. 1995 and Jun. 2008. The survival value of SL and the prognostic factors were studied. Results In the early -stage (stage I and II ) patients, the overall survival (OS) and progress free survival (PFS) were longer in the group with SL than without SL (P = 0. 020, P = 0. 025 ). However, there was no significant difference of OS and PFS between the patients with and without SL in the advanced disease. The OS and PFS were better in cases with negative lymph node than that with positive lymph node( P 〈 0. 001 ). Stage, metastasis of retroperitoneal lymph node, and residual disease were the independent prognosis factors of PFTC ( P = 0. 021, P = 0. 038, P = 0.031 ). Conclusion Staging operation including SL should be done in early - stage PFTC, so as to achieve the accurate staging and following treatment. In advanced cases, the debulking surgery to reduce residual disease as much as possible is critical to survival.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2010年第6期443-445,共3页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 原发性输卵管癌 腹膜后淋巴结切除术 生存期 预后因素 PFTC systematic lymphadenectomy survival prognostic factor
  • 相关文献

参考文献11

  • 1连丽娟.林巧稚妇科肿瘤学[M].北京:人民卫生出版社,2006:452-458.
  • 2Inal MM, Hanhan M, Pilanei B, et al. Fallopian tube malignancies: experience of Social Security Agency Aegean Maternity Hospital [ J]. Int J Gynecol Cancer, 2004,14:595-599.
  • 3Demopoulos RI, Aronov R, Mesia A. Clues to the pathogenesis of fallopian tube carcinoma: a morphological and immunohistochemical case control study [ J]. Int J Gynecol Pathol, 2001, 20 : 128-132.
  • 4Hirst JE, Gard GB, McIllroy K, et al. High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy [ J]. Int J Gynecol Cancer, 2009, 19(5) :826-829.
  • 5Ajithkumar TV, Minimole AL, John MM, et al. Primary fallopian tube carcinoma [ J ]. Obstet Gynecol Surv, 2005, 60 ( 4 ) : 247-252.
  • 6Wethington SL, Herzog TJ, Seshan VE, et al. Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer [ J ]. Cancer, 2008, 113(12) :3298-3306.
  • 7Deffieux X, Morice P, Thoury A, et al. Anatomy of pelvie and para-aortic nodal spread in patients with primary fallopian tube carcinoma[J]. J Am Coll Surg, 2005, 200(1) :45-48.
  • 8Klein M, Rosen AC, Lahousen M, et al. Lymphadenectomy in primary carcinoma of the fallopian tube [ J]. Cancer Lett, 1999, 147(1-2) :63-66.
  • 9Kim YM, Jung MH, Kim DY, et al. Systematic lymphadenectomy improves survival in patients with advanced-stage primary fallopian tube cancer [J]. Tohoku J Exp Med, 2009, 218( 1 ) :5- 9.
  • 10Papadimitriou CA, Markaki S, Lianos E, et al. Clinicopathological features of primary fallopian tube carcinoma : a single institution experience[ J]. Eur J Gynaecol Oncol, 2009, 30(4) : 389-395.

共引文献12

同被引文献15

  • 1徐望红,项永兵,金凡,戴奇,阮志贤,程家蓉,舒晓鸥,高玉堂.哺乳与子宫内膜癌关系的病例对照研究[J].肿瘤,2004,24(5):417-421. 被引量:4
  • 2Massimo M, Enzo R, Alessandro Q, et al. Vaginal treatment of endometrial cancer: role in the elderly[]]. WorldJ Surg Oncol, 2011(9):74.
  • 3Folkins AK, Jarboe EA, Saleemuddin A, et al. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations[J]. Gynecol Oncol, 2008, 109(2):168-173.
  • 4Stewart SL, Wike JM, Foster SL, et al. The incidence f primary fallopian tube cancer in the United States[J]. Gynecol Oncol, 2007, 107(3):392-397.
  • 5Wethington SL, Herzog TJ, Seshan VF, et al. Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primaryfallopian tube and ovarian cancer[J]. Cancer. 2008.11 ,(17.oqp,-o.
  • 6Semmel DR, Folkins AK, Hirsch MS, et al. Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria[J]. Mod Pathol, 2009, 22(8):985-988.
  • 7Culton LK, Deavers MT, Silva EG, et al. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube:a clinicopathologic study of 13 cases[J]. Am J Surg Pathol, 2006, 30(7):844-849.
  • 8Kulac I, Usubutun A. Microscopic lesions of fallopian tubes in endometrioid carcinoma of the endometrium: How effective are the macroscopic tubal sampling techniques[J]. J Gynecol Oncol, 2013, 24(2):114-119.
  • 9Takeshima N, Hirai Y, Yamauchi K, et al. Clinical usefulness of endometrial aspiration cytology and CA-125 in the detection of fallopian tube carcinoma[J]. Acta Cytol, 1997, 41 (5):1445-1450.
  • 10Koo YJ, Kwon YS, Lim KT, et al. Para-aortic lymphadenectomy for primary fallopian tube cancer[J]. Int J Gynaecol Obstet, 2011, 112(1):18-20.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部